TrialJournal of virology2000

A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.

F Verrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.